GlaxoSmithKline reported 89.04B in Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Alcon AG ALC:SW 27.79B 209M
Amgen AMGN:US $ 59294M 98M
Artemis Alpha ATS:LN 164.51M 22.2M
AstraZeneca AZN:LN 96579M 3694M
Bayer BAYN:GR € 128794M 3012M
Biogen BIIB:US $ 25081.4M 1467M
Bristol Myers Squibb BMY:US $ 100357M 2677M
Eli Lilly And LLY:US $ 47063.6M 144.3M
Fresenius FRE:GR € 76112M 2998M
Fresenius Medical Care FME:GR € 36070M 1345.87M
Galapagos GLPG:NA € 5040.08M 60.23M
Genmab GEN:DC DK 24914M 287M
Gilead Sciences GILD:US $ 62870M 210M
GlaxoSmithKline GSK:LN 89045M 644M
Glaxosmithkline GSK:US $ 89045M 644M
Hikma Pharmaceutical HIK:LN 4.75B 375M
Lonza Group LONN:SW 16.74B 284M
Merck MRK:GR € 48717M 2482M
Novartis NOVN:VX SF 122910M 2308M
Orion ORNBV:FH € 1270.8M 46.1M
Recordati REC:IM € 3984.1M 341.14M
Regeneron Pharmaceuticals REGN:US $ 27205.8M 857.1M